AU2022220331A1 - Treatment of myopia - Google Patents

Treatment of myopia Download PDF

Info

Publication number
AU2022220331A1
AU2022220331A1 AU2022220331A AU2022220331A AU2022220331A1 AU 2022220331 A1 AU2022220331 A1 AU 2022220331A1 AU 2022220331 A AU2022220331 A AU 2022220331A AU 2022220331 A AU2022220331 A AU 2022220331A AU 2022220331 A1 AU2022220331 A1 AU 2022220331A1
Authority
AU
Australia
Prior art keywords
composition
copper
administered
containing agent
myopia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022220331A
Other languages
English (en)
Inventor
Balamurali Ambati
Sarah A. MOLOKHIA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation Inc
Original Assignee
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation Inc filed Critical University of Utah Research Foundation Inc
Publication of AU2022220331A1 publication Critical patent/AU2022220331A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AU2022220331A 2021-02-11 2022-02-11 Treatment of myopia Pending AU2022220331A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163148344P 2021-02-11 2021-02-11
US63/148,344 2021-02-11
PCT/US2022/016205 WO2022174094A1 (en) 2021-02-11 2022-02-11 Treatment of myopia

Publications (1)

Publication Number Publication Date
AU2022220331A1 true AU2022220331A1 (en) 2023-09-28

Family

ID=82837328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022220331A Pending AU2022220331A1 (en) 2021-02-11 2022-02-11 Treatment of myopia

Country Status (9)

Country Link
US (1) US20240122974A1 (https=)
EP (1) EP4291163A4 (https=)
JP (1) JP2024508706A (https=)
KR (1) KR20240021734A (https=)
CN (1) CN118234482A (https=)
AU (1) AU2022220331A1 (https=)
CA (1) CA3208185A1 (https=)
TW (1) TW202302121A (https=)
WO (1) WO2022174094A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250109788A (ko) * 2018-01-05 2025-07-17 유니버시티 오브 유타 리서치 파운데이션 근시 진행의 치료

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058015A1 (en) * 2000-06-01 2004-03-25 Yuanjin Tao Compositions and methods for treating eye discomfort and eye disease
US20040001791A1 (en) * 2000-11-16 2004-01-01 Zeiler Kenneth T. Composition, method of use, and devices for the treatment of onychomycosis
US9504603B2 (en) * 2012-04-02 2016-11-29 Ocuject, Llc Intraocular delivery devices and methods therefor
JP6898734B2 (ja) * 2013-10-07 2021-07-07 オクジェクト, リミテッド ライアビリティー カンパニーOcuject, Llc 針アセンブリ
US11065275B2 (en) * 2016-03-08 2021-07-20 University Of Utah Research Foundation Cross-linking agents and associated methods
KR20250109788A (ko) * 2018-01-05 2025-07-17 유니버시티 오브 유타 리서치 파운데이션 근시 진행의 치료
CN109776623B (zh) * 2019-03-05 2021-05-07 潍坊科技学院 一种含氟草酰胺同/异核化合物的制备方法与应用

Also Published As

Publication number Publication date
CA3208185A1 (en) 2022-08-18
TW202302121A (zh) 2023-01-16
CN118234482A (zh) 2024-06-21
KR20240021734A (ko) 2024-02-19
US20240122974A1 (en) 2024-04-18
JP2024508706A (ja) 2024-02-28
WO2022174094A1 (en) 2022-08-18
EP4291163A1 (en) 2023-12-20
EP4291163A4 (en) 2025-01-01

Similar Documents

Publication Publication Date Title
US12544400B2 (en) Treatment of myopic progression
JP2023153926A (ja) 交差架橋剤、及び関連する方法
JP2025028826A (ja) 乱視の治療
AU2026201640A1 (en) Multi-agent ocular formulations and treatment methods
US20240122974A1 (en) Treatment of myopia